The Biggest Psychedelic News Stories of the Week – April 14
A wave of psychedelic news has hit the headlines as we see multiple states pushing for the decriminalization and advancement of psychedelics.
A wave of psychedelic news has hit the headlines as we see multiple states pushing for the decriminalization and advancement of psychedelics.
Health Canada’s decision to deny a terminally ill Saskatoon man permission to continue psychedelic psilocybin therapy has drawn a lot of attention and criticism from psychedelic advocates.
No, magic mushrooms are illegal in Canada. Psilocybin is strictly prohibited under Schedule III of the CDSA.
Benjamin Lightburn of Filament Health discusses the ins and outs of being a licensed dealer of naturally derived psilocybin in Canada and internationally.
The ayahuasca church was granted an exemption on religious grounds and is one of six Canadian organizations allowed to utilize it.
This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!
This week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good news for alcohol abuse treatment.
A sexual misconduct scandal, a data scandal, and an elder abuse scandal haunt psychedelics leader MAPS, currently being scrutinized by Health Canada.
This week in psychedelic business news: Small Pharma prepares big DMT studies; Health Canada approves a psilocybin PTSD study.
Two psychedelic industry insiders reflect on the progress and flaws within Health Canada’s recent amendment to the Special Access Program.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.